linderalactone and Acute-Lung-Injury

linderalactone has been researched along with Acute-Lung-Injury* in 1 studies

Other Studies

1 other study(ies) available for linderalactone and Acute-Lung-Injury

Article	Year
A natural sesquiterpene lactone isolinderalactone attenuates lipopolysaccharide-induced inflammatory response and acute lung injury through inhibition of NF-κB pathway and activation Nrf2 pathway in macrophages. International immunopharmacology, 2023, Volume: 124, Issue:Pt B Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; I-kappa B Kinase; Interleukin-6; Kelch-Like ECH-Associated Protein 1; Lactones; Lipopolysaccharides; Macrophages; Mice; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha	2023

Article

Year

A natural sesquiterpene lactone isolinderalactone attenuates lipopolysaccharide-induced inflammatory response and acute lung injury through inhibition of NF-κB pathway and activation Nrf2 pathway in macrophages.

International immunopharmacology, 2023, Volume: 124, Issue:Pt B

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; I-kappa B Kinase; Interleukin-6; Kelch-Like ECH-Associated Protein 1; Lactones; Lipopolysaccharides; Macrophages; Mice; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha

2023